Adapalene NDC 72162-1048

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1048Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1048Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1048-2	72162104802	1 TUBE in 1 CARTON (72162-1048-2) / 45 g in 1 TUBEMarketed from Feb 23, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090824
Marketing start: Jun 30, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 72162-1048_c9e91243-b1c9-457f-9172-e32010ebe9ebSPL ID c9e91243-b1c9-457f-9172-e32010ebe9ebSPL set ID 79454b4c-3fd4-4e6d-b984-908f8cc8ab6dRxCUI 313852UNII 1L4806J2QF
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162104802 followed by a unit qualifier and the quantity

Package 72162-1048-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Adapalene cream is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)